Diabetes News and Research

Latest Diabetes News and Research

Enzymes could be targeted to kill dangerous pathogens

Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.

28 Aug 2009

The Research Partnership study reveals that diabetes can have a major effect on people's lives

A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%) of type 2 patients reporting that the condition has impacted on either their ability or their desire to have sex.

28 Aug 2009

NIH panel releases report on the pertinence of family health history information in improving health

Though most Americans are familiar with completing a questionnaire about their family health history when visiting health care providers, an independent panel was convened by the National Institutes of Health this week to critically assess exactly what we know and what we need to learn about how this process relates to improving health.

28 Aug 2009

Springer signs agreement with The Endocrine Society to co-publish a new journal

Springer, one of the leading publishers in the fields of science, technology and medicine, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010.

28 Aug 2009

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Cardium Therapeutics today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.

28 Aug 2009

Alimera Sciences' $5 million extension of Series C financing closed

Alimera Sciences, Inc., today announced that it has closed a $5 million extension of its Series C financing which was originally completed in March 2008.

28 Aug 2009

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

AgaMatrix, Inc., the makers of WaveSense blood glucose meters, announced today their continued commitment to educate health care professionals and patients on the importance of blood glucose meter (BGM) accuracy for all patients.

28 Aug 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.

28 Aug 2009

Fatostatin lowers the activity of genes associated with cholesterol synthesis

A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell Press journal.

27 Aug 2009

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Rutgers University Professor Dipak Sarkar has received a $3.5 million MERIT Award from the National Institutes of Health (NIH) to continue researching the damaging effects of alcohol on the nervous systems of the unborn.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called “EMP Diagnostics Inc.” (“EDI”). The business of the new company will focus on the application of Haber’s Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.

27 Aug 2009

New study of diabetes patients across five European countries launched by GfK Healthcare

GfK Healthcare’s Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients’ attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.

27 Aug 2009

American Scientific Resources to acquire the intellectual property of Disintegrator home needle destruction device

American Scientific Resources, Inc. (Pink Sheets: ASFX) (the Company), today confirmed that it has signed a letter of intent to acquire the intellectual property to the Disintegrator home needle destruction device (NDD) (U.S. Patent No. 6,384,362 Patent Application No.: 09/500,504).

27 Aug 2009

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.

27 Aug 2009

New genetic mechanism to control body's fat-building process identified

At a time of alarming increases in obesity and associated diseases -- and fiery debates about the cost of health care -- a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.

27 Aug 2009

Integrated Healthcare Association releases healthcare performance results for California

New healthcare performance results released by the Integrated Healthcare Association (IHA) include a comparison of average composite scores across eight California regions in four performance measurement domains: clinical quality, patient experience, information technology-enabled systemness, and coordinated diabetes care.

27 Aug 2009

GI Dynamics to present additional results of mechanisms of actions clinical study

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.

27 Aug 2009

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.

27 Aug 2009

Diabetes News and Research

Latest Diabetes News and Research

Enzymes could be targeted to kill dangerous pathogens

The Research Partnership study reveals that diabetes can have a major effect on people's lives

NIH panel releases report on the pertinence of family health history information in improving health

Springer signs agreement with The Endocrine Society to co-publish a new journal

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Alimera Sciences' $5 million extension of Series C financing closed

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Fatostatin lowers the activity of genes associated with cholesterol synthesis

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

New study of diabetes patients across five European countries launched by GfK Healthcare

American Scientific Resources to acquire the intellectual property of Disintegrator home needle destruction device

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

New genetic mechanism to control body's fat-building process identified

Integrated Healthcare Association releases healthcare performance results for California

GI Dynamics to present additional results of mechanisms of actions clinical study

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in